New drugs trail many old ones in effectiveness against disease
By Sharon Begley NEW YORK (Reuters) - Despite the more than $50 billion that U.S. pharmaceutical companies have spent every year sin...
Read More »Health News
Subscribe to the Health News feed.-
-
Vaccine group suspends Sierra Leone support after funds misused
By Simon Akam FREETOWN (Reuters) - A vaccination provider set up with money from the Bill and Melinda Gates Foundation has put on ho...
Read More » -
Study finds strong genetic links for blacks with breast cancer
By Julie Steenhuysen CHICAGO (Reuters) - Researchers have been working for years to determine whether genetic glitches are driving h...
Read More » -
'Healthier' chocolates gives U.S. cocoa demand a shot in the arm
By Marcy Nicholson NEW YORK (Reuters) - In an increasingly diet-conscious nation where the amount of chocolate candy sold has tumble...
Read More » -
Clovis shares double on positive early data for lung cancer drug
(Reuters) - Clovis Oncology said initial results of an early-stage trial of its experimental lung cancer drug showed a reduction in ...
Read More » -
BioMarin's cancer drug success prompts launch of pivotal trial
(Reuters) - An experimental cancer drug from BioMarin Pharmaceutical Inc has proven to be effective in treating patients with breast...
Read More » -
Start-up tries tapping market of uninsured dental patients
SAN FRANCISCO (Reuters) - While many healthcare startups are hoping the new healthcare law going into effect next year will help dri...
Read More » -
GSK's breast cancer drug Tykerb fails in gastric cancer study
LONDON (Reuters) - GlaxoSmithKline said on Monday that its breast cancer drug lapatinib in combination with chemotherapy did not imp...
Read More » -
Synta shares fall after lung cancer trial results
CHICAGO (Reuters) - Shares of Synta Pharmaceuticals Corp fell by nearly one-third on Monday morning on disappointing results from it...
Read More » -
Exclusive: EU to fine Lundbeck, others for blocking generic drugs
By Foo Yun Chee BRUSSELS (Reuters) - A European regulator will fine Denmark's Lundbeck and eight other makers of generic drugs for l...
Read More »